SHEENA BUCKELEW: Open Payments
NPI 1588925069 · GREENVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 62 payments from 16 companies in 2025. Trend: 2023 $419 · 2024 $1,077 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $233 |
| Lilly USA, LLC | 12 | $162 |
| Novo Nordisk Inc | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $37 |
Products named: VRAYLAR, MOUNJARO, REXULTI, CAPLYTA, BREZTRI, Rybelsus, UBRELVY, LO LOESTRIN FE.
Industry payments across AL — which companies pay providers there.
